The potential role of EHR data in optimizing eligibility criteria definition for cardiovascular outcome trials

被引:0
|
作者
Kim, Jae Hyun [1 ]
Butler, Alex M. [1 ]
Ta, Casey N. [1 ]
Sun, Yingcheng [1 ]
Maurer, Mathew S. [2 ]
Weng, Chunhua [1 ]
机构
[1] Columbia Univ, Dept Biomed Informat, 622 West 168th St PH-20, New York, NY 10032 USA
[2] Columbia Univ, Dept Med, Div Cardiol, New York, NY 10032 USA
关键词
Cardiovascular outcome trials; Eligibility criteria; Clinical trial; Electronic health records; Major adverse cardiovascular events;
D O I
10.1016/j.ijmedinf.2021.104587
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Background: Cardiovascular outcome trials (CVOTs) include patients with high risks for cardiovascular events based on specific inclusion criteria. Little is known about the impact of such inclusion criteria on patient accrual and the incidence rate of cardiovascular events. Materials and methods: We evaluated the impact of criteria on the accrual and the number of cardiovascular events in a cohort of 1544 diabetes patients identified from the clinical data warehouse of New York Presbyterian Hospital / Columbia University Irving Medical Center. Results: The highest incidence rate of the composite events (i.e., cardiovascular mortality, stroke, and myocardial infarction) was observed when the inclusion criteria seek patients with underlying cardiovascular diseases or age > 60 with at least two of the risk factors including duration of diabetes, hypertension, dyslipidemia, smoking status, and albuminuria. Conclusion: Our study shows that the electronic health records could be utilized to optimize the inclusion criteria while balancing study inclusiveness and number of events.
引用
收藏
页数:4
相关论文
共 14 条
  • [1] A data-driven approach to optimizing clinical study eligibility criteria
    Fang, Yilu
    Liu, Hao
    Idnay, Betina
    Ta, Casey
    Marder, Karen
    Weng, Chunhua
    JOURNAL OF BIOMEDICAL INFORMATICS, 2023, 142
  • [2] Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials
    Sen, Anando
    Ryan, Patrick B.
    Goldstein, Andrew
    Chakrabarti, Shreya
    Wang, Shuang
    Koski, Eileen
    Weng, Chunhua
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2017, 1387 (01) : 34 - 43
  • [3] Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials
    Kim, Jae Hyun
    Ta, Casey N.
    Liu, Cong
    Sung, Cynthia
    Butler, Alex M.
    Stewart, Latoya A.
    Ena, Lyudmila
    Rogers, James R.
    Lee, Junghwan
    Ostropolets, Anna
    Ryan, Patrick B.
    Liu, Hao
    Lee, Shing M.
    Elkind, Mitchell S., V
    Weng, Chunhua
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2021, 28 (01) : 14 - 22
  • [4] Optimizing data integration in trials that use EHR data: lessons learned from a multi-center randomized clinical trial
    Sudha R. Raman
    Laura G. Qualls
    Bradley G. Hammill
    Adam J. Nelson
    Ester Kim Nilles
    Keith Marsolo
    Emily C. O’Brien
    Trials, 24
  • [5] Optimizing data integration in trials that use EHR data: lessons learned from a multi-center randomized clinical trial
    Raman, Sudha R.
    Qualls, Laura G.
    Hammill, Bradley G.
    Nelson, Adam J.
    Nilles, Ester Kim
    Marsolo, Keith
    O'Brien, Emily C.
    TRIALS, 2023, 24 (01)
  • [6] Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative
    Scott R. Evans
    Dianne Paraoan
    Jane Perlmutter
    Sudha R. Raman
    John J. Sheehan
    Zachary P. Hallinan
    Therapeutic Innovation & Regulatory Science, 2021, 55 : 545 - 552
  • [7] Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials
    Melzer, Georg
    Maiwald, Tim
    Prokosch, Hans-Ulrich
    Ganslandt, Thomas
    APPLIED CLINICAL INFORMATICS, 2021, 12 (01): : 17 - 26
  • [8] Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative
    Evans, Scott R.
    Paraoan, Dianne
    Perlmutter, Jane
    Raman, Sudha R.
    Sheehan, John J.
    Hallinan, Zachary P.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (03) : 545 - 552
  • [9] Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results: can definition of established cardiovascular disease be the missing link?
    Miguel Melo
    Cristina Gavina
    José Silva-Nunes
    Luís Andrade
    Davide Carvalho
    Diabetology & Metabolic Syndrome, 13
  • [10] Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results: can definition of established cardiovascular disease be the missing link?
    Melo, Miguel
    Gavina, Cristina
    Silva-Nunes, Jose
    Andrade, Luis
    Carvalho, Davide
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01)